Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Gastroenterology and Hepatology 6, 627 (1 November 2009) | doi:10.1038/nrgastro.2009.172
GERD: Novel approach to treatment
Abstract
Keywood, C. et al. A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-esophageal reflux disease. Gut 58, 1192–1199 (2009).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
